Kenvue Inc. $KVUE is Credit Industriel ET Commercial’s 9th Largest Position

Credit Industriel ET Commercial lifted its position in Kenvue Inc. (NYSE:KVUE) by 343.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 543,251 shares of the company’s stock after buying an additional 420,751 shares during the period. Kenvue comprises 0.7% of Credit Industriel ET Commercial’s portfolio, making the stock its 9th largest holding. Credit Industriel ET Commercial’s holdings in Kenvue were worth $9,366,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in KVUE. Physician Wealth Advisors Inc. increased its position in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares in the last quarter. Elyxium Wealth LLC bought a new position in Kenvue in the 4th quarter valued at approximately $26,000. MV Capital Management Inc. purchased a new stake in Kenvue during the 4th quarter valued at $28,000. Reflection Asset Management bought a new stake in shares of Kenvue in the 4th quarter worth $32,000. Finally, SBI Securities Co. Ltd. increased its holdings in shares of Kenvue by 82.4% in the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after purchasing an additional 1,027 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.59% of the company’s stock.

Analyst Ratings Changes

KVUE has been the topic of a number of research analyst reports. Citigroup lowered their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. UBS Group decreased their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Finally, Barclays dropped their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $19.33.

Kenvue Price Performance

NYSE KVUE opened at $19.97 on Tuesday. The stock has a market capitalization of $38.34 billion, a price-to-earnings ratio of 23.49, a PEG ratio of 1.50 and a beta of 0.47. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The business’s fifty day moving average price is $17.90 and its 200-day moving average price is $17.73.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.Kenvue’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.24 earnings per share. On average, equities analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.2%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.